AstraZeneca PLC Sponsored BDR Logo

AstraZeneca PLC Sponsored BDR (A1ZN34)

Bovespa

Currency in BRL
142.81
+0.44 (+0.31%)

Real-time Data

01:00 PM

Day's Range

141.26
143.20

52 wk Range

130.02
190.40

Profile - A1ZN34 - AstraZeneca PLC Sponsored BDR

Profile

Mic Code

BVMF

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

96.10K


AstraZeneca PLC Sponsored BDR represents a Brazilian Depositary Receipt issued for the global biopharmaceutical company, AstraZeneca PLC. This financial asset allows investors in Brazil to gain exposure to AstraZeneca’s shares without dealing in the complexities of international investing directly. The primary function of these BDRs is to facilitate access to global markets for Brazilian investors, providing a diversified portfolio option while maintaining local trading conditions and currency norms. AstraZeneca is renowned for its innovative work in pharmaceuticals, including treatments for cardiovascular, renal & metabolism, oncology, respiratory & immunology, and vaccine development. By impacting the healthcare and pharmaceutical sectors, AstraZeneca BDRs play a significant role in the evolving bio-sciences market, drawing investor interest due to the company’s continuous research and development focus. These BDRs, traded on the Brazilian stock exchange, offer a way for local investors to participate in the growth of a key global pharmaceutical leader, reflecting the value and performance of AstraZeneca's international operations.

Profile Details

Type

Depositary Receipt

Address

1 Francis Crick Avenue

City

Cambridge

Zip

CB2 0AA

Country

United Kingdom

Phone

44 20 3749 5000

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.